| |
| |
|
| Insider
Information: |
Vagelos P Roy |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
717,380 |
|
|
Indirect Shares
|
1,322,453 |
|
|
| Direct
Value |
$312,768,276 |
|
|
|
Indirect Value
|
$169,901,771 |
|
|
| Total
Shares |
2,039,833 |
|
|
| Total
Value |
$482,670,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2023-04-03 |
312,578 |
2023-04-03 |
154,526 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2009-12-23 |
404,802 |
2009-12-23 |
1,167,927 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
266 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2013-05-06 |
4 |
S |
$263.15 |
$3,548,550 |
I/I |
(13,482) |
114,018 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2008-08-04 |
4 |
A |
$0.00 |
$0 |
I/I |
114,309 |
114,309 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2013-05-06 |
4/A |
S |
$263.15 |
$3,162,537 |
I/I |
(12,018) |
114,750 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2010-07-07 |
4 |
A |
$0.00 |
$0 |
I/I |
125,000 |
125,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-04-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
259 |
125,493 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
291 |
125,752 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-10-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
304 |
126,043 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-07-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
357 |
126,347 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-04-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
302 |
126,704 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2012-11-19 |
4 |
S |
$160.59 |
$5,219,974 |
I/I |
(32,500) |
127,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2011-01-03 |
4 |
AS |
$34.04 |
$304,896 |
D/D |
(8,957) |
131,555 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2012-11-28 |
4 |
AS |
$175.03 |
$1,225,910 |
D/D |
(7,004) |
135,576 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2007-06-27 |
4 |
AS |
$0.00 |
$0 |
I/I |
(97,799) |
138,737 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2011-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
30,778 |
140,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2011-09-02 |
4 |
AS |
$60.35 |
$5,439,674 |
D/D |
(88,955) |
140,087 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2010-12-17 |
4 |
AS |
$32.06 |
$404,469 |
D/D |
(12,616) |
140,512 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2014-02-27 |
4 |
OE |
$9.49 |
$899,952 |
D/D |
70,879 |
140,839 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-01-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
338 |
141,292 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-10-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
347 |
141,630 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-07-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
373 |
141,977 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-04-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
446 |
142,350 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chairman of the Board |
• • – |
2012-11-27 |
4 |
AS |
$175.19 |
$6,353,788 |
D/D |
(36,246) |
142,580 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-01-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
414 |
142,796 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-10-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
349 |
143,210 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-07-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
341 |
143,559 |
0 |
- |
|
266 Records found
|
|
Page 3 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
